Shutdown-Delayed NIH Meeting Races to Fund Disease Research
Published Date: 11/28/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding a closed virtual meeting on December 18-19, 2025, to review important grant applications about infectious diseases. This meeting was delayed due to a government shutdown but is now urgent to keep vital health research funding on track. Scientists and researchers waiting on NIH grants will be affected by this quick rescheduling.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Urgent Rescheduling of NIH Grant Review
The NIH review meeting for infectious disease grant applications is being held urgently on December 18-19, 2025 after a 43-day government shutdown delayed it. The meeting was published less than 15 days before the date so evaluations can be submitted to national advisory councils for timely funding recommendations.
Closed Meeting Protects Applicant Confidentiality
The December 18-19, 2025 NIH review meeting will be closed to the public because discussions could disclose confidential trade secrets or personal information in grant applications. This keeps applicants' patentable material and personal data private during the evaluation process.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-21501, Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Final Guidance
Starting in 2026, Medicare will negotiate lower prices for some expensive drugs to help save money for patients and the government. This new rule affects drug makers, who must follow price limits through 2028, including a first-ever renegotiation cycle. These changes aim to make medicines more affordable while protecting certain special drugs, with clear deadlines and rules set by CMS.
Next: 2025-21503, Center For Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 28, 2026, to review cancer research grant applications. These meetings are private to protect secret ideas and personal info. Researchers applying for grants and the NIH are the main players, with no new costs or deadlines announced.